10-Aug-2010
Update on Acrux female health products
17-Jun-2010
Acrux CEO nominated in 2010 Entrepreneur Of The Year awards
15-Apr-2010
AXIRON New Drug Application accepted for review by the FDA
16-Mar-2010
Acrux and Eli Lilly sign global licensing deal for AXIRON
16-Mar-2010
Market Update - A New Era For Acrux
27-Jan-2010
Acrux Submits New Drug Application for AXIRON to FDA
12-Nov-2009
Update on Ellavie regulatory process for Australian market
6-Nov-2009
Acrux appoints Credit Suisse as corporate advisor
29-Sep-2009
Acrux Announces Successful AXIRON Phase 3 Trial Results
24-Sep-2009
Acrux Signs Ellavie Distribution Agreement for Key European Markets